JOSTRA and BIOSAFE Conclude an Exclusive Licence for a New Autotransfusion Technology
In a move to further broaden its extensive portfolio of open heart surgery equipment, JOSTRA announced that it has concluded an exclusive […]
World's Largest Resource for Cardiovascular Perfusion
In a move to further broaden its extensive portfolio of open heart surgery equipment, JOSTRA announced that it has concluded an exclusive […]
COVID-19 contributes to cardiovascular complications, including acute myocardial injury as a result of acute coronary syndrome, myocarditis, stress-cardiomyopathy, arrhythmias, cardiogenic shock, and cardiac arrest.
The purpose of this freestanding editorial is to highlight the hematologic consequences of the COVID-19 pandemic as they provide clues and challenges for the delivery of high-quality patient care.